Guangdong Jiaying Pharmaceutical Co Ltd Capital Reinvestment Ratio
Guangdong Jiaying Pharmaceutical Co Ltd capital reinvestment ratio. Guangdong Jiaying Pharmaceutical Co Ltd (002198) has a Capital Reinvestment Ratio of 0.10x as of December 2024, meaning it reinvests 0% of its operating cash flow (CN¥43.63 Million) in capital expenditures (CN¥4.57 Million). Check Guangdong Jiaying Pharmaceutical Co Ltd (002198) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Guangdong Jiaying Pharmaceutical Co Ltd (2004–2025)
Capital reinvestment ratio of Guangdong Jiaying Pharmaceutical Co Ltd from 2004 to 2025. This chart tracks Guangdong Jiaying Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 22 annual periods. Also explore Guangdong Jiaying Pharmaceutical Co Ltd (002198) equity growth momentum to track the company's year-over-year net asset growth rate.
Guangdong Jiaying Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2004–2025)
Guangdong Jiaying Pharmaceutical Co Ltd capital reinvestment ratio by year from 2004 to 2025. For the full cash flow conversion analysis, see 002198 cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 12.21x | CN¥9.00 Million | CN¥109.92 Million | ▲ +1819.7% |
| 2024 | 0.64x | CN¥60.85 Million | CN¥38.70 Million | ▲ +1137.4% |
| 2023 | 0.05x | CN¥98.45 Million | CN¥5.06 Million | ▼ -49.1% |
| 2022 | 0.10x | CN¥27.15 Million | CN¥2.74 Million | ▲ +123.1% |
| 2021 | 0.05x | CN¥51.80 Million | CN¥2.34 Million | ▼ -62.5% |
| 2020 | 0.12x | CN¥96.87 Million | CN¥11.68 Million | ▼ -91.7% |
| 2019 | 1.45x | CN¥12.96 Million | CN¥18.82 Million | ▲ +907.3% |
| 2018 | 0.14x | CN¥62.10 Million | CN¥8.95 Million | ▼ -76.1% |
| 2017 | 0.60x | CN¥30.63 Million | CN¥18.44 Million | ▲ +166.9% |
| 2016 | 0.23x | CN¥53.13 Million | CN¥11.98 Million | ▼ -71.4% |
| 2015 | 0.79x | CN¥42.31 Million | CN¥33.42 Million | ▼ -17.3% |
| 2014 | 0.96x | CN¥103.36 Million | CN¥98.74 Million | ▲ +113.3% |
| 2013 | 0.45x | CN¥19.46 Million | CN¥8.72 Million | ▼ -64.1% |
| 2012 | 1.25x | CN¥5.27 Million | CN¥6.58 Million | ▼ -90.9% |
| 2011 | 13.78x | CN¥781.89K | CN¥10.77 Million | ▲ +661.8% |
| 2010 | 1.81x | CN¥19.70 Million | CN¥35.62 Million | ▼ -34.2% |
| 2009 | 2.75x | CN¥27.98 Million | CN¥76.95 Million | ▲ +1.4% |
| 2008 | 2.71x | CN¥10.71 Million | CN¥29.05 Million | ▲ +473.6% |
| 2007 | 0.47x | CN¥18.35 Million | CN¥8.68 Million | ▼ -3.7% |
| 2006 | 0.49x | CN¥26.37 Million | CN¥12.95 Million | ▲ +42.1% |
| 2005 | 0.35x | CN¥17.63 Million | CN¥6.09 Million | ▼ -83.2% |
| 2004 | 2.05x | CN¥8.78 Million | CN¥18.04 Million | — |